9 results
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Polyarteritis Nodosa ... Polyangiitis (GPA ... Polyangiitis (MPA ... #Treatment #ACR2021 ... #rheumatology
2021 ACR/VF Guidelines for Management of Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA)

#Granulomatosis #Polyangiitis #GPA
Polyangiitis (GPA ... #Polyangiitis #GPA ... #ACR2021 #Management ... #rheumatology # ... algorithm #vasculitis
2021 ACR/VF Guidelines for Management of Polyarteritis Nodosa (PAN)

#PAN #Polyarteritis #Nodosa #ACR2021 #Management #rheumatology #algorithm #vasculitis
Polyarteritis Nodosa ... (PAN) #PAN #Polyarteritis ... #Nodosa #ACR2021 ... #Management #rheumatology ... #algorithm #vasculitis
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Polyangiitis (GPA ... Algorithm - ACR ... #Polyangiitis #GPA ... #Treatment #ACR2021 ... #rheumatology
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
Polyarteritis Nodosa ... (PAN) - Vasculitis ... Management Algorithm ... #Treatment #ACR2021 ... #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Polyangiitis (EGPA ... Algorithm - ACR ... of Preference (Can ... #Treatment #ACR2021 ... #rheumatology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
) - Vasculitis Management ... Algorithm - ACR ... #Treatment #ACR2021 ... #Guidelines #algorithm ... #rheumatology
Relapsing Polychondritis

What is it?
Recurrent inflammation of the cartilage in the body (Autoimmune disorder)

Who?
• Most frequently: 40
Polyarteritis Nodosa ... • Lymphoma • GPA ... /EGPA • RA Diagnosis ... affected tissue Treatment ... #diagnosis #management
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
CALR-calreticulin gene, or MPL-thrombopoietin ... • Treatment is ... • Treatment algorithms ... #diagnosis #management ... #hematology